Home Newsletters Muscle Cell News Osteocrin, a Novel Myokine, Prevents Diabetic Cardiomyopathy via Restoring Proteasomal Activity

Osteocrin, a Novel Myokine, Prevents Diabetic Cardiomyopathy via Restoring Proteasomal Activity

0
Scientists investigated the role and underlying molecular basis of osteocrin (OSTN) in diabetic cardiomyopathy. Neonatal rat cardiomyocytes were isolated and stimulated with high glucose to verify the role of OSTN in vitro.
[Cell Death & Disease]
7992332 {7992332:VXLHD5U2} apa 50 1 163553 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version